2005 Minnesota Statutes - 148.571 — Use of topical ocular drugs.

     148.571 Use of topical ocular drugs. 


    Subdivision 1.    Authority.  Subject to the provisions 
 of sections 148.57, subdivision 3, and 148.571 to 148.574, 
 licensed optometrists may administer topical ocular drugs to the 
 anterior segment of the human eye during an eye examination in 
 the course of practice in their normal practice setting, solely 
 for the purposes of determining the refractive, muscular, or 
 functional origin of sources of visual discomfort or difficulty, 
 and detecting abnormalities which may be evidence of disease.  


    Subd. 2.    Drugs specified.  For purposes of sections 
 148.57, subdivision 3, and 148.571 to 148.574, "topical ocular 
 drugs" means: 


    (1) commercially prepared topical anesthetics as follows: 
 proparacaine HC1 0.5 percent, tetracaine HC1 0.5 percent, and 
 benoxinate HC1 0.4 percent; 


    (2) commercially prepared mydriatics as follows: 
 phenylephrine HC1 in strength not greater than 2.5 percent and 
 hydroxyamphetamine HBr in strength not greater than 1 percent; 
 and 


    (3) commercially prepared cycloplegics/mydriatics as 
 follows:  tropicamide in strength not greater than 1 percent and 
 cyclopentolate in strength not greater than 1 percent.  


    HIST: 1982 c 388 s 1; 1986 c 444